These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3514471)

  • 1. [Results of ofloxacin treatment of experimental urinary tract infections].
    Ritzerfeld W
    Infection; 1986; 14 Suppl 1():S45-6. PubMed ID: 3514471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin: therapeutic activity in experimental infections.
    Guerra L; Erani E; Xerri L
    Chemioterapia; 1986 Dec; 5(6):375-8. PubMed ID: 3467874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females.
    Ode B; Walder M; Forsgren A
    Scand J Infect Dis; 1987; 19(6):677-9. PubMed ID: 3327150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
    Tietgen K; Schulz E; Boness J; Marre R
    Immun Infekt; 1986 Jul; 14(4):152-5. PubMed ID: 2943665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the antibacterial effect of nitrofurantoin and two nitrofuran compounds on experimental Escherichia coli pyelonephritis.
    Prát V; Konícková L; Hammarström A
    Acta Pharmacol Toxicol (Copenh); 1969; 27(6):445-52. PubMed ID: 4905775
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.
    Rubinstein E; Mark Z; Keren G; Alkan M; Berger S; Bogokowski B
    Infection; 1986; 14 Suppl 1():S20-5. PubMed ID: 3514469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bacteriological diagnosis and treatment of urinary tract infection.
    Motzkin D
    J Urol; 1972 Mar; 107(3):454-7. PubMed ID: 4551629
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ofloxacin treatment in nephrologic problem patients with various degrees of chronic renal failure (including dialysis treatment). Preliminary results].
    Schulz W; Dörfler A
    Infection; 1986; 14 Suppl 1():S97-101. PubMed ID: 3456988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical report of treatment of urinary tract infections with lividomycin].
    Ichikawa T; Nakano I; Hirokawa I; Nakamura M
    Jpn J Antibiot; 1972 Dec; 25(6):389-95. PubMed ID: 4579558
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present status of the treatment of urological infections].
    Ukhin AV
    Antibiot Med Biotekhnol; 1985 May; 30(5):384-91. PubMed ID: 3896135
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of fleroxacin and ofloxacin in experimental pyelonephritis.
    Ritzerfeld W
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():119-22. PubMed ID: 3144529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effects of lividomycin in urinary tract infections caused by Pseudomonas aeruginosa].
    Tanaka E; Nakazawa S; Sato H
    Jpn J Antibiot; 1972 Dec; 25(6):446-51. PubMed ID: 4198944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
    Guibert J; Acar JF
    Pathol Biol (Paris); 1986 May; 34(5):494-7. PubMed ID: 3534729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Uripret-system for the identification and sensitivity testing of the causative agents of urinary tract infections].
    Juretschke R; Kollias G; Rinsche KG
    MMW Munch Med Wochenschr; 1978 Jan; 120(4):111-2. PubMed ID: 342923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of lividomycin in urinary tract infections].
    Tokito T; Shigematsu S; Eto K
    Jpn J Antibiot; 1972 Dec; 25(6):432-5. PubMed ID: 4579564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Outlook and experience in using ofloxacin in urology].
    Derevianko II; Kotliarova GA; Siniukhin VN
    Antibiot Khimioter; 1996; 41(9):89-94. PubMed ID: 9005797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with lividomycin in urinary tract infections].
    Nijima T; Fujita Y; Kondo K; Amano M
    Jpn J Antibiot; 1972 Dec; 25(6):427-31. PubMed ID: 4579563
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections].
    Naber KG; Adam D; Wittenberger R; Bartosik-Wich B
    Infection; 1986; 14 Suppl 1():S60-4. PubMed ID: 2420725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].
    Weber P; Dib C; Durand C; Moniot-Ville N
    Pathol Biol (Paris); 2005 Mar; 53(2):125-8. PubMed ID: 15708658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.